Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 219-702-5 | CAS number: 2500-88-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 27 July - 18 Aug 2011
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline-conform study under GLP without deviations.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Laboratories B.V.; AD Horst, The Netherlands
- Age at study initiation: 8-10 weeks
- Weight at study initiation: 17.7 - 21.0 g
- Housing: in groups in Macrolon Type II / III cages with wire mesh top with granulated soft wood bedding
- Diet: pelleted standard diet (Harlan Laboratories B.V., Horst, The Netherlands), ad libitum
- Water: tap water, ad libitum
- Acclimation period: at least 5 days prior to the start of dosing
ENVIRONMENTAL CONDITIONS
- Temperature (°C):22 +/- 2°C
- Humidity (%): 45-77 %
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 27.07. To: 18.08.2011 - Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 2.5, 5 or 10%
- No. of animals per dose:
- 4
- Details on study design:
- RANGE FINDING TESTS:
- Compound solubility: The highest test item concentration, which can be technically used was a 10 % solution in actone:olive oil (4+1).
At higher concentrations, an applicable formulation of the test item was not achieved, neither by the use of other vehicle nor by using additional methods to formulate the test item (e.g. vortexing, sonicating, warming to 37°C)
- Irritation: performed on two female mice, by topical application of concentrations of 5, and 10 % on each ear each on three consecutive days. Prior to application of the test item and before sacrifice the body weight was determined. Clinical signs were recorded at least once daily. Eventual signs of local skin irritation were documented and a score was used to grade a possible reddening of the ear skin. Furthermore, prior to application of the test item (day 1), on day 3 and before sacrifice (day 6) the ear thickness was determined using a micrometer. Additionally, for both animals, the ears were punched after sacrifice (day 6) at the apical area using a biopsy punch and were immediately pooled per animal and weighed using an analytical balance.
On day 3 and 4, the animal treatedwith 5 and 10% test item concentration showed reddening of the ear skin (score 2). On day 5, the animal treated with 10% test item concentration showed reddening of the ear skin (score 1). Thus, the test item in the main study was assayed at 2.5, 5 and 10%. The highest concentration tested was the highest level that could be achieved whilst avoiding systemic toxicity and excessive local skin irritation in the pre-experiment.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: Local Lymph Node Assay (LLNA)
- Criteria used to consider a positive response: The sensitivity and reliability of the experimental technique employed was assessed by use of a
substance which is known to have skin sensitisation properties in CBA/CaOlaHsd mice (α-Hexylcinnamaldehyde in acetone:olive oil, 4:1 )
TREATMENT PREPARATION AND ADMINISTRATION:
25 µl was spread to the entire dorsal surface of each ear of each mouse once daily for three consecutive days. On day 6 an injection of 250 µl phosphate buffered saline (PBS) containing20.1 µCi of 3H-methyl thymidine (3H-TdR) was made into the tail vein of each experimental mouse. Five hours
later, the draining Auricular lymph node of each ear was excised and pooled per group (8 nodes per group) into PBS. A single cell suspension of lymph node cells was prepared from each group. After washing two times with phosphate buffered saline the lymph node cells were resuspended in 5 % trichloroacetic acid and incubated at approximately +4 °C for at least 18 hours for precipitation of macromolecules. The precipitates were then resuspended in 5 % trichloroacetic acid and transferred to plastic scintillation vials. The level of 3HTdR incorporation was then measured on a ß-scintillation counter. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- The mean values and standard deviations were calculated.
- Positive control results:
- The sensitivity and reliability of the experimental technique employed was assessed by use of Hexylcinnaldehyde which is known to have skin sensitisation properties in CBA/CaOlaHsd mice.
The EC3 value was calculated to be 12.1%. - Key result
- Parameter:
- SI
- Value:
- 1.86
- Test group / Remarks:
- 2.5 % in acetone:olive oil (4+1 v/v)
- Key result
- Parameter:
- SI
- Value:
- 2.21
- Test group / Remarks:
- 5 % in acetone:olive oil (4+1 v/v)
- Key result
- Parameter:
- SI
- Value:
- 2.53
- Test group / Remarks:
- 10 % in acetone:olive oil (4+1 v/v)
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The test itemHostanox SE 10 was found to be not a skin sensitiser under the described conditions.
- Executive summary:
The sensitization potential was investigated according to OECD Guideline 429.
The test item concentrations chosen for the LLNA test were 2.5, 5, 10 %.
No deaths occurred during the study period. No systemic or local findings were observed during the study period. The body weight of the animals was within the range commonly recorded for animals of this strain and age.
Reference
Table 1: Calculation and Results
Vehicle: acetone:olive oil (4+1 v/v)
Test item concentration % (w/w) |
Group |
Measurement DPM |
Calculation |
Result |
||
DPM-BGa) |
number of lymph nodes |
DPM per lymph nodeb) |
S.I. |
|||
--- |
BG I |
27 |
--- |
--- |
--- |
--- |
--- |
BG II |
22 |
--- |
--- |
--- |
--- |
0 |
1 |
1502 |
1478 |
7 |
211.1 |
1.00 |
2.5 |
2 |
3162 |
3138 |
8 |
392.2 |
1.86 |
5 |
3 |
3753 |
3729 |
8 |
466.1 |
2.21 |
10 |
4 |
4291 |
4267 |
8 |
533.3 |
2.53 |
BG = Background (1 ml 5% trichloroacetic acid) in duplicate
1 = Control Group
2-4= Test Group
S.I. = Stimulation Index
a) = The mean value was taken from the figures BG I and BG II
b) = Since the lymph nodes of the animals of a dose group were pooled, DPM/node was determined by dividing the measured value by the number of lymph nodes pooled
The EC3 value could not be calculated, since all S.I.´s are below the threshold value of 3.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
No deaths occurred during the study period. No systemic or local findings were observed during the study period. The body weight of the animals was within the range commonly recorded for animals of this strain and age.
Migrated from Short description of key information:
The sensitization potential of Dioctadecyl disulphide was investigated according to OECD Guideline 429. The test item concentrations chosen for the LLNA test were 2.5, 5, 10 %.
Justification for selection of skin sensitisation endpoint:
Guideline-conform study under GLP without deviations.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Dioctadecyl disulphide did not show skin sensitizing properties in the Local Lymph Node Assay according to the current OECD guidelines. Allergic skin reactions or case reports of acute contact dermatitis to Dioctadecyl disulphide have not been described in the literature. Therefore, the substance does not have to be classified as a skin sensitizer.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
Tato webová stránka používá cookies, aby se vám naše stránky používaly co nejlépe.